SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
155.20    2.40 (1.57%)
Bid:
155.00
Ask:
155.40
Spread: 0.40 (0.258%)
Market Cap: £888.23m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

AGM Statement

25 Apr 2013 07:00

RNS Number : 1771D
Elementis PLC
25 April 2013
 



 

 

 

25 April 2013

 

 

AGM / Interim Management Statement

 

Elementis plc (ELM.L, "the Company" or "the Group"), the Global Specialty Chemicals Company, today issues its Interim Management Statement for the three months ended 31 March 2013.

 

Commenting on the Company's performance Group Chief Executive, David Dutro, said: "In the first three months of 2013 we have made a solid start to the year, particularly as we are comparing our performance to a very strong quarter in 2012. We continue to benefit from the diverse nature of our business, both in terms of geography and end market. At Elementis we are committed to creating our own growth opportunities in an uncertain economic environment and the Group has a number of exciting growth initiatives that are at an early stage of development, including the new coatings additives plant in North America, as well as the acquisitions of Watercryl in Brazil and Hi-Mar in the US. Each of these should add momentum to our performance as the year progresses. Overall, we anticipate full year earnings will be in line with market expectations."

 

In Specialty Products, sales volumes in the first quarter were 7 per cent higher than the same period last year with good progress in all key business areas.

·; In coatings additives, sales volumes in North America were 3 per cent higher than the previous year, while volumes in Latin America were 134 per cent higher, as each region benefited from the recent acquisitions of Hi-Mar in North America and Watercryl in Latin America. Volumes in Asia Pacific were 4 per cent higher, while in Europe sales volumes grew by 7 per cent as the business continued to succeed in identifying new business opportunities to offset underlying economic weakness.

·; In personal care, sales volumes were 4 per cent higher than the same period last year.

·; Sales volumes in the oil and gas drilling sector improved significantly in the current period compared to the second half of 2012, when an industry inventory adjustment caused a temporary downturn in order patterns. As a result, sales volumes in the first quarter were 61 per cent higher than the average quarterly sales in the second half of 2012 and only 5 per cent below the first quarter of 2012, which was the strongest sales quarter in the business's history.

In Chromium, as expected, first quarter sales were impacted by a scheduled plant maintenance shutdown. The business operates a pro-active maintenance programme, designed to ensure a stable operating performance with extended periods between shutdowns. The previous maintenance shutdown was done during the second half of 2011, so sales in the first quarter of 2012 were unaffected. The most recent maintenance was carried out in the early part of 2013, thereby reducing sales volumes in the first quarter and, as a consequence, sales volumes were 15 per cent lower than the previous year. However, consistent with the strategy for this business of "stable earnings and cash flow", sales for the year as a whole are expected to be similar to 2012.

The Group's balance sheet remains in a strong position and is expected to be in a net cash position at the end of the year.

 

 

Enquiries:

Elementis

+44 (0) 207 408 9300

Brian Taylorson, Finance Director

FTI Consulting

+44 (0) 207 831 3113

Deborah Scott

Matthew Cole

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMDGGDSUUDBGXS
Date   Source Headline
11th Jul 20255:32 pmRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20256:04 pmRNSTransaction in Own Shares
8th Jul 20255:27 pmRNSTransaction in Own Shares
7th Jul 20255:54 pmRNSTransaction in Own Shares
4th Jul 20255:30 pmRNSTransaction in Own Shares
3rd Jul 20256:05 pmRNSTransaction in Own Shares
2nd Jul 20255:49 pmRNSTransaction in Own Shares
1st Jul 20255:42 pmRNSTransaction in Own Shares
30th Jun 20256:02 pmRNSTransaction in Own Shares
27th Jun 20255:51 pmRNSTransaction in Own Shares
26th Jun 20255:55 pmRNSTransaction in Own Shares
25th Jun 20255:49 pmRNSTransaction in Own Shares
24th Jun 20255:52 pmRNSTransaction in Own Shares
23rd Jun 20255:31 pmRNSTransaction in Own Shares
20th Jun 20256:22 pmRNSTransaction in Own Shares
18th Jun 20256:06 pmRNSTransaction in Own Shares
17th Jun 20255:43 pmRNSTransaction in Own Shares
16th Jun 20256:07 pmRNSTransaction in Own Shares
13th Jun 20255:53 pmRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20255:38 pmRNSTransaction in Own Shares
10th Jun 20255:33 pmRNSTransaction in Own Shares
10th Jun 20253:49 pmRNSDirector/PDMR Shareholding
10th Jun 20253:48 pmRNSDirector/PDMR Shareholding
9th Jun 20256:19 pmRNSTransaction in Own Shares
6th Jun 20255:10 pmRNSTransaction in Own Shares
5th Jun 20255:54 pmRNSTransaction in Own Shares
4th Jun 20255:56 pmRNSTransaction in Own Shares
3rd Jun 20255:55 pmRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNSDirector/PDMR Shareholding
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSCommencement of Share Buyback
27th May 20257:00 amRNSSale of Talc business and intended buyback launch
7th May 20254:55 pmRNSHolding(s) in Company
1st May 202510:20 amRNSTotal Voting Rights
29th Apr 202512:24 pmRNSResult of AGM
29th Apr 20257:00 amRNSFirst quarter trading update
25th Mar 20254:22 pmRNSAnnual Financial Report & Notice of AGM
18th Mar 20254:22 pmRNSHolding(s) in Company
18th Mar 20253:10 pmRNSAdditional Listing
13th Mar 20257:00 amRNSAppointment of new Chief Executive Officer
6th Mar 20257:00 amRNSPreliminary results year ended 31 December 2024
3rd Mar 20259:41 amRNSBlock listing Interim Review
3rd Mar 20259:31 amRNSTotal Voting Rights
3rd Feb 20259:53 amRNSTotal Voting Rights
21st Jan 20257:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.